首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Senior care pharmacist

缩写:SR CARE PHARM

ISSN:2639-9636

e-ISSN:2639-9644

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引661
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Merton Lee,Emma Stein,Lauren Roygardner Merton Lee
Background In the United States, pharmacist-administered immunization is associated with increased rates of vaccination. But older adults may reside in long-term care settings not served by the community pharmacies associated with immunizat...
Jennifer Woo,Carla Washington,Dorothy Aikin et al. Jennifer Woo et al.
Background Vibegron, a beta₃-adrenergic receptor agonist for overactive bladder, can be administered as an intact tablet or crushed and mixed with applesauce for patients with dysphagia. Objectives To evaluate the suitability of crushed vi...
Jeannie K Lee,Lynne T Tomasa,Michael W Nagy et al. Jeannie K Lee et al.
Background There is an urgent need to prepare our health care workforce for the aging population. Pharmacy programs should equip students with foundational knowledge about aging and therapeutic skills for the rising demands of health care f...
Ashley Strong,Eric Steele Ashley Strong
Background Urinary incontinence is a condition prevalent in older adults and has the potential to impact health and quality of life in patients. Commonly prescribed anticholinergic medications have significant side effects that are often he...
Emily M Hitt Emily M Hitt
Alzheimer's disease is the most common cause of dementia. Behavioral and psychological symptoms in dementia (BPSD) are neuropsychiatric signs accompanying dementia that carry a significant impact on prognosis and management. Management of B...
Creaque C Tyler,Aireona C Armagon,Ildebrando E Garcia et al. Creaque C Tyler et al.
Lupus treatment recently saw the approval of new drugs after a 12-year gap since the last approval of belimumab (Benlysta) in 2011. This article reviews these newly FDA-approved agents, which have demonstrated efficacy and safety in the man...